A soft tissue regeneration filler and preparation method thereof
A stable and injectable silk fibropropion/polyethylene glycol-polycaprolactone binet copolymer was prepared through the dual network structure and mannitol auxiliary materials of silk fibropropion/polyethylene glycol-polycaprolactone binet coagulation. The gel filler solves the problems of fast degradation speed of silk fibroprotein hydrogels and toxicity of crosslinking agents in the prior art, and achieves long-term tissue filling and regeneration effects.
Patent Information
- Application Number
- CN202310502608.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-06
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-05-06
AI Technical Summary
The existing silk fibroprotein hydrogels degrade rapidly in the body, and the crosslinking structure is unstable, making it difficult to achieve long-term tissue filling effect. The crosslinking agent used in chemical crosslinking is toxic. The gels of physical crosslinking method are in the microenvironment. It is easily decomposed by protease.
Silk fibroprotein/polyethylene glycol-polycaprolactone binet gel particles are used to form a binet structure by combining silk fibroprotein and polyethylene glycol-polycaprolactone copolymer, and mannitol is added as The auxiliary materials are prepared by ultrapure water dialysis and freeze-drying, etc., to form an injectable soft tissue regeneration filler.
The prepared silk fibroprotein/polyethylene glycol-polycaprolactone double network gel has a dense and stable structure, a long degradation cycle in the body, can achieve immediate filling and promote tissue regeneration, prolong the maintenance time of the filler, and does not Toxic residue.
Smart Images

Figure CN116271224B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical technology, and specifically relates to a soft tissue regeneration filler and a preparation method thereof. Background Art
[0002] With the rapid development of the medical beauty industry, injectable filling materials are receiving more and more attention. As the most commonly used injectable filling material, cross-linked sodium hyaluronate gel has good immediate filling and shaping effects. However, due to the rapid degradation of sodium hyaluronate in the tissue environment, sodium hyaluronate itself does not have the tissue regeneration function to stimulate the growth of tissue cells and collagen production. As a result, patients usually need repeated injections every 6 months or so, which greatly increases the patient's treatment costs and adverse experiences. In recent years, regenerative medical beauty filling materials have gradually emerged. With the approval of collagen fillers, poly-L-lactic acid facial fillers, polycaprolactone fillers and ethylene glycol-L-lactic acid copolymer fillers, medical beauty filling materials have also developed from traditional physical filling materials to tissue regeneration filling materials.
[0003] Since silk fibroin was approved as a biomaterial by the U.S. Food and Drug Administration (FDA) in 1993, it has been widely used in the fields of biomedicine and tissue engineering due to its excellent mechanical properties, good biocompatibility, biodegradability and versatility of structural adjustment. Silk fibroin can be processed into materials with different structures such as solutions, silk films, microspheres / microparticles, hydrogels, scaffolds and electrospun membranes, and used in the fields of wound repair, drug carriers, tissue filling and artificial organs. In recent years, silk fibroin products that have been launched on the market include the SERI surgical stent developed by Allergan for abdominal wall reconstruction and plastic surgery. Sofregen in the United States has developed a SilkVoice natural silk protein injection for the treatment of vocal cord medialization and vocal cord insufficiency. Suzhou Soho Biomaterials Co., Ltd. has developed a silk fibroin wound dressing for the healing and repair of scald and burn wounds. In addition to the products that have been launched on the market, some companies have also conducted clinical trials on their products, including silk fibroin bandages for ligament reconstruction, silk fibroin tissue meshes for femoral groove hernia, silk fibroin sutures for oral surgery, and silk fibroin porous tissue regeneration scaffolds for meniscus cartilage repair. At present, there is still a blank in the preparation of silk fibroin for facial plastic surgery filling products. According to relevant research, as a material with excellent biocompatibility, silk fibroin can promote the growth, differentiation and proliferation of skin fibroblasts. At the same time, the various amino acids released by silk fibroin after degradation in the body can accelerate cell metabolism, promote collagen synthesis, enhance skin tension and elasticity, and decompose pigments. Therefore, if silk fibroin is prepared into an injectable soft tissue filling material for facial plastic surgery, it will have great application potential. When silk fibroin is used as an injectable soft tissue filling material for facial plastic surgery, it needs to be prepared into a hydrogel or microsphere that can be injected through a syringe, and then injected into the skin tissue to achieve the effect of cosmetic filling.
[0004] At present, the methods for preparing silk fibroin hydrogel mainly include chemical crosslinking and physical crosslinking. Most of the crosslinking agents used in the silk fibroin hydrogel prepared by the chemical crosslinking method, such as glutaraldehyde, genipin, horseradish peroxidase, etc., have high toxicity. Therefore, after the hydrogel is implanted into the tissue, the toxicity problem caused by the crosslinking agent residue is difficult to solve. Compared with chemical crosslinking, the physically crosslinked silk fibroin hydrogel has better biosafety and is more suitable for use as a tissue filling material in the field of medical cosmetology. At present, the reported preparation methods of silk fibroin physical gel include water-soluble organic solvent induction, surfactant induction, pH induction, ultrasound / oscillation induction and electric field induction. However, the common characteristics of the silk fibroin physical gel prepared by the above methods are that the internal molecular distribution of the gel is relatively loose, and the crosslinking structure has poor stability, which leads to it being easily decomposed by the tissue microenvironment and various proteases after being implanted into the body tissue, thereby failing to achieve a long-term tissue filling effect.
[0005] As another soft tissue regeneration filling material, polycaprolactone (PCL) and polyethylene glycol-polycaprolactone copolymer have a long in vivo degradation cycle, and the filling effect can generally be maintained for more than 3 years. At the same time, this type of polymer can also stimulate the M2 polarization of macrophages in the skin immune system through its own foreign body reaction in the tissue and the 6-hydroxycaproic acid released during its degradation process. M2 polarized macrophages will highly express TGF-β (transforming growth factor) and other related cytokines, further inducing fibroblasts to accelerate the secretion of collagen, ultimately achieving the effect of tissue filling at the injection site and reshaping the skin contour. In particular, as an amphiphilic copolymer, polyethylene glycol-polycaprolactone can effectively induce the formation of β-overlapping physical cross-linking structures between silk fibroin molecules, and at the same time form a double network gel with silk fibroin. When used as a soft tissue filler, this silk fibroin / polyethylene glycol-polycaprolactone double network gel not only has the biological activity of silk fibroin itself, but also has the long degradation cycle of polyethylene glycol-polycaprolactone copolymer, which can stimulate the growth of fibroblasts in the tissue and the secretion of collagen, thereby improving the defects of traditional cross-linked sodium hyaluronate gel fillers, such as short maintenance time and inability to stimulate tissue regeneration. Summary of the invention
[0006] In view of the deficiencies in the prior art, the present invention provides
[0007] The technical scheme of the present invention is as follows: a soft tissue regeneration filler, comprising silk fibroin / polyethylene glycol-polycaprolactone double network gel particles and auxiliary materials.
[0008] Preferably, the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles include regenerated silk fibroin and polyethylene glycol-polycaprolactone copolymer, wherein the mass ratio of the regenerated silk fibroin to the polyethylene glycol-polycaprolactone copolymer is 28-40:50.
[0009] Preferably, the auxiliary material is mannitol.
[0010] Preferably, the ratio of the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles to the auxiliary material is 20:1.
[0011] Preferably, the preparation method of the regenerated silk fibroin is: take degummed silk and dissolve it in a LiBr solution; add the LiBr solution of the degummed silk into a dialysis bag, dialyze with ultrapure water to remove the LiBr in the solution; freeze-dry the dialyzed silk fibroin solution to obtain the regenerated silk fibroin.
[0012] Preferably, the concentration of the LiBr solution is 9.3M.
[0013] Preferably, the preparation method of the polyethylene glycol-polycaprolactone copolymer is:
[0014] 1) Add ε-caprolactone and polyethylene glycol to a round-bottom flask, heat to 110° C. and stir until the two raw materials are completely melted and mixed evenly; during the heating and stirring process, use a vacuum pump to evacuate the flask to remove moisture in the sample.
[0015] 2) The reaction flask was flushed with argon gas, and a catalyst was added under stirring conditions, and the reaction temperature was increased to 130° C. to initiate the ring-opening polymerization of ε-caprolactone to obtain a polyethylene glycol-polycaprolactone copolymer precursor;
[0016] 3) The polyethylene glycol-polycaprolactone copolymer precursor was dissolved in dichloromethane and then precipitated with ether, and the process was repeated 5 times, followed by vacuum drying to obtain a purified polyethylene glycol-polycaprolactone copolymer.
[0017] Preferably, the mass ratio of ε-caprolactone to polyethylene glycol is (2.5-1):(1-2.5).
[0018] Preferably, the catalyst is stannous octoate.
[0019] Preferably, the preparation method of the silk fibroin / polyethylene glycol-polycaprolactone double network gel is:
[0020] i) taking regenerated silk fibroin and dissolving it in ultrapure water;
[0021] ii) taking polyethylene glycol-polycaprolactone copolymer and dissolving it in dimethyl sulfoxide;
[0022] iii) adding the solution of step ii) to the solution of step i) with stirring, and continuing to stir to mix the two solutions evenly;
[0023] iv) incubating the mixed solution at room temperature to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel;
[0024] v) adding the double network gel into ultrapure water, stirring and washing, and obtaining a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
[0025] Preferably, the preparation method of the soft tissue regeneration filler is:
[0026] S1: adding the silk fibroin / polyethylene glycol-polycaprolactone double network gel into a grinder, and crushing the gel to prepare the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles.
[0027] S2 Weigh the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add mannitol, and stir to mix and dissolve completely;
[0028] S3 fills the silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol into a prefilled syringe, and sterilizes it with wet heat to obtain the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
[0029] The invention discloses an application of the soft tissue regeneration filler in the preparation of a tissue regeneration medical cosmetic filling material.
[0030] Beneficial effects of the present invention: The silk fibroin / polyethylene glycol-polycaprolactone gel with a double network structure prepared in the present invention has a dense and stable structure and a long degradation period in vivo. In particular, the injectable soft tissue filler prepared by the silk fibroin / polyethylene glycol-polycaprolactone double network gel not only has the advantages of outstanding immediate filling effect and good plasticity when used as a cosmetic filling material, but also can induce and stimulate the regeneration of tissue fibroblasts and collagen, prolonging the effect maintenance time of the filler, and is an innovative tissue regeneration medical cosmetic filling material. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 A schematic flow chart showing a method for preparing a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler according to an embodiment of the present invention;
[0032] Figure 2 A picture showing soluble silk fibroin obtained according to the preparation method of Example 1 of the present invention is shown;
[0033] Figure 3 The infrared spectrum data of the soluble silk fibroin obtained by the preparation method according to Example 1 of the present invention are shown;
[0034] Figure 4 The amino acid content data of the soluble silk fibroin obtained according to the preparation method of Example 1 of the present invention are shown;
[0035] Figure 5 The infrared spectrum data of the polyethylene glycol-polycaprolactone copolymer obtained according to the preparation method of Example 2 of the present invention are shown;
[0036] Figure 6 The gel permeation chromatography (GPC) molecular weight data of the polyethylene glycol-polycaprolactone copolymer obtained according to the preparation method of Example 2 of the present invention are shown;
[0037] Figure 7 The gel permeation chromatography (GPC) molecular weight data of the polyethylene glycol-polycaprolactone copolymer obtained according to the preparation method of Example 3 of the present invention are shown;
[0038] Figure 8The gel permeation chromatography (GPC) molecular weight data of the polyethylene glycol-polycaprolactone copolymer obtained according to the preparation method of Example 4 of the present invention are shown;
[0039] Fig. 9 The infrared spectrum data of the silk fibroin / polyethylene glycol-polycaprolactone double network gel obtained according to the preparation method of Example 5 of the present invention are shown;
[0040] Fig.10 A picture showing a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler obtained according to the preparation method of Example 9 of the present invention;
[0041] Fig.11 The cytotoxicity data of the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler obtained according to the preparation method of Example 9 of the present invention are shown;
[0042] Fig.12 The anatomical diagrams of the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler obtained according to the preparation method of Example 9 of the present invention after being injected into the subcutaneous tissue of rats for different time periods are shown;
[0043] Fig.13 The H&E staining images of tissue sections of rats injected with the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler prepared according to the preparation method of Example 9 of the present invention at different time periods are shown;
[0044] Fig.14 The Masson staining images of tissue sections of rats injected with the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler prepared according to the preparation method of Example 9 of the present invention at different time periods are shown. DETAILED DESCRIPTION
[0045] The following embodiments can enable those skilled in the art to more fully understand the present invention, but the present invention is not limited to the scope of the embodiments.
[0046] Example 1
[0047] A method for preparing a regenerated silk fibroin material, the method comprising the following steps:
[0048] 1) Take 50 g of degummed silk and dissolve it in 450 mL of LiBr solution (9.3 M);
[0049] 2) Add the LiBr solution of degummed silk into a dialysis bag and dialyze it with ultrapure water for 5 times to remove the LiBr in the solution;
[0050] 3) placing the dialyzed silk fibroin solution in a freeze drying box and freeze drying to obtain a regenerated silk fibroin material.
[0051] Figure 2 The picture of the regenerated silk fibroin material prepared in this example is shown. Figure 3 The infrared spectrum data of the silk fibroin prepared in this example are shown. Figure 3 It can be seen that silk fibroin is at 1700cm -1 ~1600cm -1 , 1590cm -1 ~1460cm -1 , and 1280cm -1 ~1190cm -1 There are characteristic peaks at the bottom, corresponding to the amide I band, amide II band and amide III band of silk fibroin. Figure 4 The amino acid content test data of the silk fibroin prepared in this example are shown. Figure 4 It can be seen that the double-crosslinked silk fibroin microspheres contain 18 characteristic amino acids of regenerated silk fibroin, and the total amino acid content is greater than 99%.
[0052] Example 2
[0053] A polyethylene glycol-polycaprolactone copolymer material, the preparation method of the material comprises the following steps:
[0054] 1) Weigh 286g of ε-caprolactone and 114g of polyethylene glycol (4KDa) (polymerization mass ratio of 2.5:1) into a round-bottom flask, heat to 110°C and stir until the two raw materials are completely melted and mixed evenly. During the heating and stirring process, use a vacuum pump to evacuate the flask to remove moisture from the sample.
[0055] 2) The reaction flask was flushed with argon gas, and 0.4 g of stannous octoate catalyst was added under stirring conditions, and the reaction temperature was increased to 130° C. to initiate the ring-opening polymerization of ε-caprolactone for 18 hours to obtain a polyethylene glycol-polycaprolactone copolymer precursor;
[0056] 3) The polyethylene glycol-polycaprolactone copolymer precursor was dissolved in 2 L of dichloromethane, and then precipitated with 10 L of ether. After repeating this process for 5 times, the polyethylene glycol-polycaprolactone copolymer was vacuum dried to obtain a purified polyethylene glycol-polycaprolactone copolymer.
[0057] Figure 5 The infrared spectrum of the polyethylene glycol-polycaprolactone copolymer synthesized in this example is shown. Figure 5 It can be seen that 2945cm -1 and 1725cm -1 is the characteristic absorption peak of polycaprolactone in the copolymer, 1107cm -1 and 961cm-1 It is the characteristic absorption peak of polyethylene glycol in the copolymer.
[0058] Figure 6 The gel permeation chromatography (GPC) diagram of the polyethylene glycol-polycaprolactone synthesized in this example is shown. Figure 6 It can be seen that the weight average molecular weight (Mw) of polyethylene glycol-polycaprolactone is 21912 Da.
[0059] Example 3
[0060] A polyethylene glycol-polycaprolactone copolymer material, the preparation method of the material comprises the following steps:
[0061] 1) Weigh 200g of ε-caprolactone and 200g of polyethylene glycol (4KDa) (polymerization mass ratio is 1:1) and add them into a round-bottom flask, heat to 110°C and stir until the two raw materials are completely melted and mixed evenly. During the heating and stirring process, use a vacuum pump to evacuate the flask to remove moisture from the sample.
[0062] 2) The reaction flask was flushed with argon gas, and 0.4 g of stannous octoate catalyst was added under stirring conditions, and the reaction temperature was increased to 130° C. to initiate the ring-opening polymerization of ε-caprolactone for 18 hours to obtain a polyethylene glycol-polycaprolactone copolymer precursor;
[0063] 3) The polyethylene glycol-polycaprolactone copolymer precursor was dissolved in 2 L of dichloromethane, and then precipitated with 10 L of ether. After repeating this process for 5 times, the polyethylene glycol-polycaprolactone copolymer was vacuum dried to obtain a purified polyethylene glycol-polycaprolactone copolymer.
[0064] Figure 7 The gel permeation chromatography (GPC) diagram of the polyethylene glycol-polycaprolactone synthesized in this example is shown. Figure 7 It can be seen that the weight average molecular weight (Mw) of polyethylene glycol-polycaprolactone is 10947 Da.
[0065] Example 4
[0066] A polyethylene glycol-polycaprolactone copolymer material, the preparation method of the material comprises the following steps:
[0067] 1) Weigh 114 g of ε-caprolactone and 286 g of polyethylene glycol (4 KDa) (polymerization mass ratio of 0.4:1) into a round-bottom flask, heat to 110°C and stir until the two raw materials are completely melted and mixed evenly. During the heating and stirring process, use a vacuum pump to evacuate the flask to remove moisture from the sample.
[0068] 2) The reaction flask was flushed with argon gas, and 0.4 g of stannous octoate catalyst was added under stirring conditions, and the reaction temperature was increased to 130° C. to initiate the ring-opening polymerization of ε-caprolactone for 18 hours to obtain a polyethylene glycol-polycaprolactone copolymer precursor;
[0069] 3) The polyethylene glycol-polycaprolactone copolymer precursor was dissolved in 2 L of dichloromethane, and then precipitated with 10 L of ether. After repeating this process for 5 times, the polyethylene glycol-polycaprolactone copolymer was vacuum dried to obtain a purified polyethylene glycol-polycaprolactone copolymer.
[0070] Figure 8 The gel permeation chromatography (GPC) diagram of the polyethylene glycol-polycaprolactone synthesized in this example is shown. Figure 8 It can be seen that the weight average molecular weight (Mw) of polyethylene glycol-polycaprolactone is 8578 Da.
[0071] Example 5
[0072] A silk fibroin / polyethylene glycol-polycaprolactone double network gel, wherein the preparation method of the double network gel comprises the following steps:
[0073] 1) 28 g of the silk fibroin prepared in Example 1 was dissolved in 400 mL of ultrapure water;
[0074] 2) 50 g of the polyethylene glycol-polycaprolactone copolymer prepared in Example 2 was dissolved in 200 mL of dimethyl sulfoxide (DMSO) solution;
[0075] 3) adding the polyethylene glycol-polycaprolactone copolymer solution to the stirring silk fibroin solution, and continuing to stir at 600 rpm for 30 min to mix the two solutions evenly;
[0076] 4) incubating the mixed solution at room temperature for 24 hours to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel;
[0077] 5) The double network gel was added into 3 L of ultrapure water, stirred and washed for 6 times to obtain a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
[0078] Fig. 9 The infrared spectrum of the silk fibroin / polyethylene glycol-polycaprolactone double network gel synthesized in this example is shown. Fig. 9 It can be seen that the infrared characteristic absorption peaks of the double network gel include silk fibroin at 1700 cm -1 ~1600cm -1 , 1590cm -1 ~1460cm -1 , and 1280cm -1 ~1190cm -1The characteristic absorption peak of polyethylene glycol-polycaprolactone is at 2945cm -1 , 1725cm -1 , 1107cm -1 , 961cm -1 The characteristic absorption peaks of
[0079] Example 6
[0080] A silk fibroin / polyethylene glycol-polycaprolactone double network gel, wherein the preparation method of the double network gel comprises the following steps:
[0081] 1) 28 g of the silk fibroin prepared in Example 1 was dissolved in 400 mL of ultrapure water;
[0082] 2) 50 g of the polyethylene glycol-polycaprolactone copolymer prepared in Example 3 was dissolved in 200 mL of dimethyl sulfoxide (DMSO) solution;
[0083] 3) adding the polyethylene glycol-polycaprolactone copolymer solution to the stirring silk fibroin solution, and continuing to stir at 600 rpm for 30 min to mix the two solutions evenly;
[0084] 4) incubating the mixed solution at room temperature for 24 hours to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel;
[0085] 5) The double network gel was added into 3 L of ultrapure water, stirred and washed for 6 times to obtain a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
[0086] Example 7
[0087] A silk fibroin / polyethylene glycol-polycaprolactone double network gel, wherein the preparation method of the double network gel comprises the following steps:
[0088] 1) 28 g of the silk fibroin prepared in Example 1 was dissolved in 400 mL of ultrapure water;
[0089] 2) 50 g of the polyethylene glycol-polycaprolactone copolymer prepared in Example 4 was dissolved in 200 mL of dimethyl sulfoxide (DMSO) solution;
[0090] 3) adding the polyethylene glycol-polycaprolactone copolymer solution to the stirring silk fibroin solution, and continuing to stir at 600 rpm for 30 min to mix the two solutions evenly;
[0091] 4) incubating the mixed solution at room temperature for 24 hours to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel;
[0092] 5) The double network gel was added into 3 L of ultrapure water, stirred and washed for 6 times to obtain a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
[0093] Example 8
[0094] A silk fibroin / polyethylene glycol-polycaprolactone double network gel, wherein the preparation method of the double network gel comprises the following steps:
[0095] 1) 40 g of the silk fibroin prepared in Example 1 was dissolved in 400 mL of ultrapure water;
[0096] 2) 50 g of the polyethylene glycol-polycaprolactone copolymer prepared in Example 2 was dissolved in 200 mL of dimethyl sulfoxide (DMSO) solution;
[0097] 3) adding the polyethylene glycol-polycaprolactone copolymer solution to the stirring silk fibroin solution, and continuing to stir at 600 rpm for 30 min to mix the two solutions evenly;
[0098] 4) incubating the mixed solution at room temperature for 24 hours to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel;
[0099] 5) The double network gel was added into 3 L of ultrapure water, stirred and washed for 6 times to obtain a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
[0100] Example 9
[0101] A silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler, the preparation method of the soft tissue regeneration filler comprises the following steps:
[0102] 1) The silk fibroin / polyethylene glycol-polycaprolactone double network gel prepared in Example 5 was added into a grinder, and the gel was crushed at a grinding speed of 10000 rpm, and the crushing was repeated 3 times to prepare silk fibroin / polyethylene glycol-polycaprolactone double network gel particles.
[0103] 2) Weigh 300 g of silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add 15 g of mannitol, and stir to mix and dissolve completely;
[0104] 3) The silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol are filled into a prefilled syringe and sterilized by wet heat at 121 degrees Celsius for 15 minutes to obtain a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
[0105] Fig.10The actual picture of the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler synthesized in this example is shown.
[0106] Fig.11 The cytotoxicity data of the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler synthesized in this example are shown. Fig.11 It can be seen that after the extract of the injectable soft tissue filler is co-cultured with fibroblasts, the cell survival rate reaches more than 100%.
[0107] Fig.12 The following are anatomical pictures of the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler synthesized in this example injected into the subcutaneous tissue of rats at 1 month, 6 months and 12 months. Fig.12 It can be seen that the filler has not been completely degraded 12 months after implantation in the tissue, and a certain volume of filler still exists at the injection site, proving that injectable soft tissue fillers not only have a long-term tissue filling effect.
[0108] Fig.13 The silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler synthesized in this example was injected into the subcutaneous tissue of rats, and the hematoxylin-eosin (H&E) staining pictures of tissue sections at 1 month, 6 months and 12 months were shown. Fig.13 It can be seen that the subcutaneous injection tissue and its surrounding cells of the rats are in good condition, and there is no obvious cell atrophy in the tissue site 12 months after the injection.
[0109] Fig.14 The following are Masson staining images of collagen fibers in tissue sections of rats injected with the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler synthesized in this example at 1 month, 6 months, and 12 months. Fig.14 It can be seen that as time goes by, the collagen proliferation effect of the subcutaneous injection tissue and its surrounding areas of the rats is significant, and the tissue sections are stained dark blue (because the attached figure is a grayscale image, the dark blue color cannot be seen, but in the actual effect figure, the dark blue is distributed in other areas except the circular cells in the figure), indicating that the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler has the beneficial effect of accelerating the secretion of autologous collagen in the tissue and stimulating tissue regeneration.
[0110] Example 10
[0111] A silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler, the preparation method of the soft tissue regeneration filler comprises the following steps:
[0112] 1) The silk fibroin / polyethylene glycol-polycaprolactone double network gel prepared in Example 6 was added into a grinder, and the gel was crushed at a grinding speed of 10000 rpm, and the crushing was repeated 3 times to prepare silk fibroin / polyethylene glycol-polycaprolactone double network gel particles.
[0113] 2) Weigh 300 g of silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add 15 g of mannitol, and stir to mix and dissolve completely;
[0114] 3) The silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol are filled into a prefilled syringe and sterilized by wet heat at 121 degrees Celsius for 15 minutes to obtain a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
[0115] Embodiment 11
[0116] A silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler, the preparation method of the soft tissue regeneration filler comprises the following steps:
[0117] 1) The silk fibroin / polyethylene glycol-polycaprolactone double network gel prepared in Example 7 was added into a grinder, and the gel was crushed at a grinding speed of 10000 rpm, and the crushing was repeated 3 times to prepare silk fibroin / polyethylene glycol-polycaprolactone double network gel particles.
[0118] 2) Weigh 300 g of silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add 15 g of mannitol, and stir to mix and dissolve completely;
[0119] 3) The silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol are filled into a prefilled syringe and sterilized by wet heat at 121 degrees Celsius for 15 minutes to obtain a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
[0120] Example 12
[0121] A silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler, the preparation method of the soft tissue regeneration filler comprises the following steps:
[0122] 1) The silk fibroin / polyethylene glycol-polycaprolactone double network gel prepared in Example 8 was added into a grinder, and the gel was crushed at a grinding speed of 15000 rpm, and the crushing was repeated 3 times to prepare silk fibroin / polyethylene glycol-polycaprolactone double network gel particles.
[0123] 2) Weigh 300 g of silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add 15 g of mannitol, and stir to mix and dissolve completely;
[0124] 3) The silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol are filled into a prefilled syringe and sterilized by wet heat at 121 degrees Celsius for 15 minutes to obtain a silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
Claims
1. A soft tissue regeneration filler, characterized in that: It comprises silk fibroin / polyethylene glycol-polycaprolactone double network gel particles and auxiliary materials; the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles are composed of regenerated silk fibroin and polyethylene glycol-polycaprolactone copolymer, wherein the mass ratio of regenerated silk fibroin to polyethylene glycol-polycaprolactone copolymer is 28:50; the auxiliary material is mannitol; the ratio of silk fibroin / polyethylene glycol-polycaprolactone double network gel particles to auxiliary materials is 20:1; The preparation method of the silk fibroin / polyethylene glycol-polycaprolactone double network gel is as follows: i) taking regenerated silk fibroin and dissolving it in ultrapure water; ii) taking polyethylene glycol-polycaprolactone copolymer and dissolving it in dimethyl sulfoxide; iii) adding the solution of step ii) to the solution of step i) with stirring, and continuing to stir to mix the two solutions evenly; iv) incubating the mixed solution at room temperature to obtain a solidified silk fibroin / polyethylene glycol-polycaprolactone double network gel; v) adding the double network gel into ultrapure water, stirring and washing, and obtaining a purified silk fibroin / polyethylene glycol-polycaprolactone double network gel.
2. The soft tissue regeneration filler according to claim 1, characterized in that: The preparation method of the regenerated silk fibroin is as follows: taking degummed silk and dissolving it in a LiBr solution; adding the LiBr solution of the degummed silk into a dialysis bag, dialyzing with ultrapure water to remove the LiBr in the solution; freeze-drying the dialyzed silk fibroin solution to obtain the regenerated silk fibroin; the concentration of the LiBr solution is 9.3M.
3. The soft tissue regeneration filler according to claim 1, characterized in that: The preparation method of the polyethylene glycol-polycaprolactone copolymer is: 1) Add ε-caprolactone and polyethylene glycol to a round-bottom flask, heat to 110°C and stir until the two raw materials are completely melted and mixed evenly; during the heating and stirring process, use a vacuum pump to evacuate the flask to remove moisture from the sample; 2) filling the flask with argon gas, adding a catalyst under stirring conditions, and raising the reaction temperature to 130° C. to initiate the ring-opening polymerization of ε-caprolactone to obtain a polyethylene glycol-polycaprolactone copolymer precursor; 3) dissolving the polyethylene glycol-polycaprolactone copolymer precursor with dichloromethane, and then precipitating with ether, repeating 5 times, and vacuum drying to obtain a purified polyethylene glycol-polycaprolactone copolymer; The mass ratio of the ε-caprolactone to the polyethylene glycol is (2.5-1):(1-2.5); and the catalyst is stannous octoate.
4. The method for preparing the soft tissue regeneration filler according to claim 1, characterized in that: The following steps are included: S1: adding the silk fibroin / polyethylene glycol-polycaprolactone double network gel into a grinder, and crushing the gel to prepare the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles; S2 Weigh the silk fibroin / polyethylene glycol-polycaprolactone double network gel particles, add mannitol, and stir to mix and dissolve completely; S3 fills the silk fibroin / polyethylene glycol-polycaprolactone double network gel microparticles dissolved with mannitol into a prefilled syringe, and sterilizes it with wet heat to obtain the silk fibroin / polyethylene glycol-polycaprolactone double network gel soft tissue regeneration filler.
5. Use of the soft tissue regeneration filler according to claim 1 in the preparation of tissue regeneration medical cosmetic filling materials.
Citation Information
Patent Citations
Silk fibroin hydrogel
CN108404204A
Silk fibroin-sodium hyaluronate cross-linked dual-network gel and preparation method thereof
CN111440340A
Hydrophilic injection type skin filling composition, preparation method and application thereof
CN114028610A
Skin wrinkle correcting injection for medical cosmetology and preparation method thereof
CN114699554A
Injection filling material and preparation process
WO2022142350A1
